International Journal of Molecular Sciences Review Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins? Lucie Coppin 1,2,3, Julie Leclerc 1,2,3, Audrey Vincent 1,2,3, Nicole Porchet 1,2,3 and Pascal Pigny 1,2,3,* 1 University of Lille, UMR-S 1172-JPARC—Jean-Pierre Aubert Research Center, F-59000 Lille, France;
[email protected] (L.C.);
[email protected] (J.L.);
[email protected] (A.V.);
[email protected] (N.P.) 2 Inserm, UMR-S 1172, Team “Mucins, Epithelial Differentiation and Carcinogenesis”, F-59000 Lille, Frances 3 CHU Lille, Service de Biochimie “Hormonologie, Métabolisme-Nutrition, Oncologie”, F-59000 Lille, France * Correspondence:
[email protected]; Tel.: + 33-320-298-850 Received: 21 December 2017; Accepted: 19 February 2018; Published: 25 February 2018 Abstract: Functional specialization of cells and tissues in metazoans require specific gene expression patterns. Biological processes, thus, need precise temporal and spatial coordination of gene activity. Regulation of the fate of messenger RNA plays a crucial role in this context. In the present review, the current knowledge related to the role of RNA-binding proteins in the whole mRNA life-cycle is summarized. This field opens up a new angle for understanding the importance of the post-transcriptional control of gene expression in cancer cells. The emerging role of non-classic RNA-binding proteins is highlighted. The goal of this review is to encourage readers to view, through the mRNA life-cycle, novel aspects of the molecular basis of cancer and the potential to develop RNA-based therapies.